Molecular Landscape of Microvascular Inflammation in Kidney Allografts

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorParis Translational Research Center for Organ Transplantation

About this trial

Microvascular inflammation in kidney allografts has been widely reappraised in the recent update of Banff classification. There is a critical need to better understand the pathophysiological mechanisms associated with the various phenotypes of microvascular inflammation that are observed in kidney transplants, particularly in order to develop targeted therapeutic approaches.

Eligibility criteria

Qualifiers

None

Disqualifiers

Inadequate biopsy according to the Banff classification

Missing data for Banff lesion scores, donor-specific antibody status, C4d staining

Biopsies showing histological signs of ischemia-reperfusion

Combined transplantation and kidney transplantation after a non-kidney solid organ transplantation

Trial design

Treatments tested in this trial

  • No intervention

Treatment groups

No treatment groups listed